This heterogeneity in gene alteration distribution was somehow confirmed in the current study; CCND1 amplification was observed in 25% of cell lines deriving from both primary and metastatic lesions but in 6% only of the in vivo melanoma human tissues. This evidence concerns the gene CCND1 and melanoma.